SCHEMBL9995116

SCHEMBL9995116

N#Cc1ccc2ccn(CCCCCl)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 4/20 0.45
TSHR P16473 4/20 0.45
HSD17B10 Q99714 4/20 0.45
HPGD P15428 3/20 0.45
GLA P06280 1/20 0.45
HTT P42858 1/20 0.45
P2RX7 Q99572 1/20 0.45
USP2 O75604 2/20 0.44
POLB P06746 1/20 0.44
CDK4 P11802 3/20 0.44
CCND1 P24385 3/20 0.44
CDC7 O00311 7/20 0.43
PRMT5 O14744 1/20 0.42
CDK2 P24941 4/20 0.42
MAP3K14 Q99558 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
MCL1 Q07820 1/20 0.40
HTR7 P34969 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9994932 0.95 ALDH1A1 (0.46) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL15577123 0.88 P2RX7 (0.56) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL16824128 0.87 P2RX7 (0.55) P2RX7CDK4CCND1CDC7PRMT5
SCHEMBL6995817 0.84 ALDH1A1 (0.49) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL8430655 0.84 ALDH1A1 (0.46) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL8255718 0.84 ALDH1A1 (0.46) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL8430662 0.80 ALDH1A1 (0.48) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL6990971 0.80 HTR2A (0.50) ALDH1A1KDM4ETSHRHSD17B10HPGD
Hydrochloric Acid SCHEMBL6995071 0.79 HTR2A (0.49) ALDH1A1KDM4ETSHRHSD17B10HPGD
SCHEMBL9995332 0.78 KMO (0.59) CDK4CCND1PRMT5MCL1HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106420754-B The purposes of benzo five-membered Azacyclyl bridged piperazine derivatives 沈阳海王生物技术有限公司 2019-11-05 CN disclosed
US-9415047-B2 Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives Liaoning Emmy Biological Pharmaceutical Co., Ltd. (CN) 2016-08-16 US disclosed
US-20150297586-A1 USE OF BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERAZINE OR PIPERIDINE DERIVATIVES Liaoning Emmy Biological Pharmaceutical Co., Ltd. (CN) 2015-10-22 US disclosed
EP-2924033-A1 USE OF BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERAZINE OR PIPERIDINE DERIVATIVES Liaoning Emmy Biological Pharmaceutical Co., Ltd (CN) 2015-09-30 EP disclosed
US-20110306638-A1 BENZISOXAZOLE PIPERIDINYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE DERIVATIVES AND THEIR USE NHWA PHARMA. CORPORATION (CN) 2011-12-15 US disclosed
CN-101759693-B Benzo-isoxazol piperidine derivative and application in preparing analgesic and sedative medicaments JIANGSU ENHUA PHARMACEUTICAL CO LTD 2011-09-14 CN disclosed
CN-101759693-A Benzo-isoxazol piperidine derivative and application in preparing analgesic and sedative medicaments NHWA PHARMACEUTICAL GROUP CO L 2010-06-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306638-A1 BENZISOXAZOLE PIPERIDINYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE DERIVATIVES AND THEIR USE HTR2A, HTR2C, HTR5A ALDH1A1 442/4885KDM4E 1382/4885TSHR 636/4885
US-20150297586-A1 USE OF BENZO FIVE-MEMBERED NITROGEN HETEROCYCLIC PIPERAZINE OR PIPERIDINE DERIVATIVES P2RX5, TBXA2R, CYP3A5 ALDH1A1 372/4885KDM4E 931/4885TSHR 2743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.